Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of GSK's MMRV Candidate Vaccine in Healthy Children
NCT00127010Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00127010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127010.